152
Views
10
CrossRef citations to date
0
Altmetric
Original Research

Serum Creatinine/Cystatin C Ratio Associated with Cross-Sectional Area of Erector Spinae Muscles and Pulmonary Function in Patients with Chronic Obstructive Pulmonary Disease

, , , , , , & show all
Pages 3513-3524 | Published online: 24 Dec 2021

References

  • Landbo C, Prescott E, Lange P, et al. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;160(6):1856–1861. doi:10.1164/ajrccm.160.6.9902115
  • Schols AMWJ, Broekhuizen R, Weling-Scheepers CA, et al. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr. 2005;82(1):53–59.
  • Ischaki E, Papatheodorou G, Gaki E, et al. Body mass and fat-free mass indices in COPD: relation with variables expressing disease severity. Chest. 2007;132(1):164–169. doi:10.1378/chest.06-2789
  • Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39(4):412–423. doi:10.1093/ageing/afq034
  • Chen L-K, Liu L-K, Woo J, et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc. 2014;15(2):95–101. doi:10.1016/j.jamda.2013.11.025
  • Heymsfield SB, Arteaga C, McManus C, et al. Measurement of muscle mass in humans: validity of the 24-hour urinary creatinine method. Am J Clin Nutr. 1983;37(3):478–494. doi:10.1093/ajcn/37.3.478
  • Proctor DN, O’Brien PC, Atkinson EJ, et al. Comparison of techniques to estimate total body skeletal muscle mass in people of different age groups. Am J Physiol. 1999;277(3 Pt 1):E489–95. doi:10.1152/ajpendo.1999.277.3.E489
  • Engstrom CM, Loeb GE, Reid JG, et al. Morphometry of the human thigh muscles. A comparison between anatomical sections and computer tomographic and magnetic resonance images. J Anat. 1991;176:139–156.
  • Mitsiopoulos N, Baumgartner RN, Heymsfield SB, et al. Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. J Appl Physiol. 1998;85(1):115–122. doi:10.1152/jappl.1998.85.1.115
  • Heymsfield SB, Smith R, Aulet M, et al. Appendicular skeletal muscle mass: measurement by dual-photon absorptiometry. Am J Clin Nutr. 1990;52(2):214–218. doi:10.1093/ajcn/52.2.214
  • Janssen I, Heymsfield SB, Baumgartner RN, et al. Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol. 2000;89(2):465–471. doi:10.1152/jappl.2000.89.2.465
  • Ikezoe T, Mori N, Nakamura M, et al. Effects of age and inactivity due to prolonged bed rest on atrophy of trunk muscles. Eur J Appl Physiol. 2012;112(1):43–48. doi:10.1007/s00421-011-1952-x
  • Lee CS, Cron DC, Terjimanian MN, et al. Dorsal muscle group area and surgical outcomes in liver transplantation. Clin Transplant. 2014;28(10):1092–1098. doi:10.1111/ctr.12422
  • Tanimura K, Sato S, Fuseya Y, et al. Quantitative assessment of erector spinae muscles in patients with chronic obstructive pulmonary disease. novel chest computed tomography-derived index for prognosis. Ann Am Thorac Soc. 2016;13(3):334–341. doi:10.1513/AnnalsATS.201507-446OC
  • Yoshizawa T, Okada K, Furuichi S, et al. Prevalence of chronic kidney diseases in patients with chronic obstructive pulmonary disease: assessment based on glomerular filtration rate estimated from creatinine and cystatin C levels. Int J Chron Obstruct Pulmon Dis. 2015;10(1):1283–1289. doi:10.2147/COPD.S80673
  • Filler G, Bökenkamp A, Hofmann W, et al. Cystatin C as a marker of GFR–history, indications, and future research. Clin Biochem. 2005;38(1):1–8. doi:10.1016/j.clinbiochem.2004.09.025
  • Baxmann AC, Ahmed MS, Marques NC, et al. Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C. Clin J Am Soc Nephrol. 2008;3(2):348–354. doi:10.2215/CJN.02870707
  • Hashizume A, Katsuno M, Banno H, et al. Longitudinal changes of outcome measures in spinal and bulbar muscular atrophy. Brain. 2012;135(Pt 9):2838–2848. doi:10.1093/brain/aws170
  • Coll E, Botey A, Alvarez L, et al. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis. 2000;36(1):29–34. doi:10.1053/ajkd.2000.8237
  • Schaeffner ES, Ebert N, Delanaye P, et al. Two novel equations to estimate kidney function in persons aged 70 years or older. Ann Intern Med. 2012;157(7):471–481. doi:10.7326/0003-4819-157-7-201210020-00003
  • Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis. 2002;40(2):221–226. doi:10.1053/ajkd.2002.34487
  • Suzuki K, Furuse H, Tsuda T, et al. Utility of creatinine/cystatin C ratio as a predictive marker for adverse effects of chemotherapy in lung cancer: a retrospective study. J Int Med Res. 2015;43(4):573–582. doi:10.1177/0300060515579116
  • Sasaki E, Nakamura M, Kida K. Reference values for spirogram and blood gas analysis in Japanese non-smoking healthy adults in Japanese. Nihon Kokyuki Gakkai Zasshi. 2001;39:383–399.
  • Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176(6):532–555. doi:10.1164/rccm.200703-456SO
  • Kato R, Mizuno S, Kadowaki M, et al. Sirt1 expression is associated with CD31 expression in blood cells from patients with chronic obstructive pulmonary disease. Respir Res. 2016;17(1):139. doi:10.1186/s12931-016-0452-2
  • Mizuno S, Ishizaki T, Kadowaki M, et al. p53 signaling pathway polymorphisms associated with emphysematous changes in COPD patients. Chest. 2017;152:58–69.
  • Nojiri M, Mizuno S, Nishiki K, et al. ADRB2 gene polymorphism and emphysema heterogeneity can modulate bronchodilator response in patients with emphysema. Pulm Pharmacol Ther. 2017;48:80–87. doi:10.1016/j.pupt.2017.09.004
  • Patel BD, Coxson HO, Pillai SG, et al. Airway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008;178(5):500–505. doi:10.1164/rccm.200801-059OC
  • Knight EL, Verhave JC, Spiegelman D, et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int. 2004;65(4):1416–1421. doi:10.1111/j.1523-1755.2004.00517.x
  • Meng L, Yang Y, Qi L-T, et al. Elevated serum cystatin C is an independent predictor of cardiovascular events in people with relatively normal renal function. J Nephrol. 2012;25(3):426–430. doi:10.5301/jn.5000020
  • McDonald M-LN, Diaz AA, Ross JC, et al. Quantitative computed tomography measures of pectoralis muscle area and disease severity in chronic obstructive pulmonary disease. A cross-sectional study. Ann Am Thorac Soc. 2014;11(3):326–334. doi:10.1513/AnnalsATS.201307-229OC
  • Kim S-W, Jung H-W, Kim C-H, et al. A new equation to estimate muscle mass from creatinine and Cystatin C. Stover CM, ed. PLoS One. 2016;11(2):e0148495. doi:10.1371/journal.pone.0148495
  • Chandrasoma B, Balfe D, Naik T, et al. Pulmonary function in patients with amyotrophic lateral sclerosis at disease onset. Monaldi Arch Chest Dis. 2012;77(3–4):129–133. doi:10.4081/monaldi.2012.146
  • Santilli V, Bernetti A, Mangone M, et al. Clinical definition of sarcopenia. Clin Cases Miner Bone Metab. 2014;11(3):177–180.
  • Schols AM, Broekhuizen R, Weling-Scheepers CA, et al. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr. 2005;82(1):53–59.
  • Purde MT, Nock S, Risch L, et al. The cystatin C/creatinine ratio, a marker of glomerular filtration quality: associated factors, reference intervals, and prediction of morbidity and mortality in healthy seniors. Transl Res. 2016;169:80–90 e1-2. doi:10.1016/j.trsl.2015.11.001
  • Perrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem. 1992;38:1933–1953. doi:10.1093/clinchem/38.10.1933
  • Stevens LA, Schmid CH, Greene T, et al. Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int. 2009;75:652–660. doi:10.1038/ki.2008.638
  • Wasén E, Isoaho R, Vahlberg T, et al. Association between markers of renal function and C-reactive protein level in the elderly: confounding by functional status. Scand J Clin Lab Invest. 2008;68(6):484–491. doi:10.1080/00365510701854983
  • Zemans RL, Jacobson S, Keene J, et al. Multiple biomarkers predict disease severity, progression and mortality in COPD. Respir Res. 2017;18(1):117. doi:10.1186/s12931-017-0597-7
  • Rutten EPA, Grydeland TB, Pillai SG, et al. Quantitative CT: associations between emphysema, airway wall thickness and body composition in COPD. Pulm Med. 2011;2011:419328. doi:10.1155/2011/419328